Jerome Durso
2017
In 2017, Jerome Durso earned a total compensation of $3.9M as Chief Operating Officer at Intercept Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $260,000 |
|---|---|
| Option Awards | $1,395,217 |
| Salary | $441,333 |
| Stock Awards | $1,738,950 |
| Other | $26,765 |
| Total | $3,862,266 |
Durso received $1.7M in stock awards, accounting for 45% of the total pay in 2017.
Durso also received $260K in non-equity incentive plan, $1.4M in option awards, $441.3K in salary and $26.8K in other compensation.
Rankings
In 2017, Jerome Durso's compensation ranked 2,667th out of 14,666 executives tracked by ExecPay. In other words, Durso earned more than 81.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,667 out of 14,666 | 82nd |
Division Manufacturing | 925 out of 5,768 | 84th |
Major group Chemicals And Allied Products | 244 out of 2,074 | 88th |
Industry group Drugs | 186 out of 1,730 | 89th |
Industry Pharmaceutical Preparations | 149 out of 1,329 | 89th |
Source: SEC filing on April 27, 2018.
Durso's colleagues
We found four more compensation records of executives who worked with Jerome Durso at Intercept Pharmaceuticals in 2017.
News
Intercept Pharmaceuticals CEO Jerome Durso's 2021 pay jumps 101% to $7.9M
May 2, 2022
Intercept Pharmaceuticals CEO Mark Pruzanski's 2020 pay slips 3% to $6.4M
April 27, 2021
Intercept Pharmaceuticals CEO Mark Pruzanski's 2019 pay jumps 46% to $6.6M
April 29, 2020
Intercept Pharmaceuticals CEO Mark Pruzanski's 2018 pay falls 26% to $4.5M
April 30, 2019